Lupus Therapeutics

Lupus Therapeutics' mission is to accelerate drug discovery and diagnostic innovation for all patients with lupus. They collaborate with the industry to match an unprecedented clinical trial network of 57 sites with the most significant lupus trials led by biotechnology and pharmaceutical leaders. They aim to eliminate the debilitating effects of lupus and help patients live longer and better lives. As part of their commitment to advancing lupus research and finding effective and safer treatments for people with lupus, the Lupus Research Alliance established Lupus Therapeutics, which serves as the administrative and financial entity for LuCIN, managing the alliance’s clinical trial programs.